BCAT1 and non-small cell lung carcinoma: While the details differ—AML sees BCAT1 limiting α-KG (resulting in hypermethylation), whereas NSCLC sees BCAT1 increasing α-KG (resulting in hypomethylation)—both cases illustrate that dysregulated BCAA metabolism can lock cells into a malignant state via epigenetic mechanisms.